{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:40:30Z","timestamp":1766580030494,"version":"build-2065373602"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K12DA000357"],"award-info":[{"award-number":["K12DA000357"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatric Clinics of North America"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.psc.2023.03.007","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T13:04:08Z","timestamp":1698066248000},"page":"691-702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adolescent Cannabis Use, Comorbid Attention-Deficit\/Hyperactivity Disorder, and Other Internalizing and Externalizing Disorders"],"prefix":"10.1016","volume":"46","author":[{"given":"Karla","family":"Molinero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse D.","family":"Hinckley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.psc.2023.03.007_bib1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1176\/appi.ajp.2018.18020202","article-title":"A\u00a0population-based analysis of the relationship between substance use and adolescent cognitive development","volume":"176","author":"Morin","year":"2019","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2023.03.007_bib2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11481-018-9813-6","article-title":"Reduction in cannabis use and functional status in physical health, mental health, and cognition","volume":"13","author":"Mooney","year":"2018","journal-title":"J\u00a0Neuroimmune Pharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.psc.2023.03.007_bib3","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/j.pain.0000000000001963","article-title":"Adverse effects of heavy cannabis use: even plants can harm the brain","volume":"162","author":"Sideli","year":"2021","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.psc.2023.03.007_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jaac.2015.02.009","article-title":"Clinic- and home-based contingency management plus parent training for adolescent cannabis use disorders","volume":"54","author":"Stanger","year":"2015","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2023.03.007_bib5","doi-asserted-by":"crossref","first-page":"e796","DOI":"10.1542\/peds.2010-0086","article-title":"Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD","volume":"126","author":"Blader","year":"2010","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.psc.2023.03.007_bib6","first-page":"56","article-title":"Cannabis use and its association with psychological disorders","volume":"50","author":"Urits","year":"2020","journal-title":"Psychopharmacol Bull"},{"issue":"3","key":"10.1016\/j.psc.2023.03.007_bib7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.chc.2019.02.006","article-title":"Integrated treatment of adolescents with Co-occurring depression and substance use disorder","volume":"28","author":"Hinckley","year":"2019","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"10","key":"10.1016\/j.psc.2023.03.007_bib8","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/s41380-018-0339-3","article-title":"Attention-deficit\/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality","volume":"25","author":"Soler Artigas","year":"2020","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2023.03.007_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/1067828X.2017.1305930","article-title":"A\u00a0Clinician\u2019s Guide to Co-occurring ADHD among adolescent substance users: comorbidity, neurodevelopmental risk, and evidence-based treatment options","volume":"26","author":"Hogue","year":"2017","journal-title":"J\u00a0Child Adolesc Subst Abuse"},{"issue":"1","key":"10.1016\/j.psc.2023.03.007_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jsat.2006.12.031","article-title":"Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment","volume":"34","author":"Chan","year":"2008","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"5","key":"10.1016\/j.psc.2023.03.007_bib11","doi-asserted-by":"crossref","first-page":"e0156614","DOI":"10.1371\/journal.pone.0156614","article-title":"I\u00a0use weed for My ADHD\": a Qualitative analysis of Online Forum discussions on cannabis use and ADHD","volume":"11","author":"Mitchell","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.psc.2023.03.007_bib12","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/ajad.12467","article-title":"Mixed-amphetamine salts increase abstinence from marijuana in patients with co-occurring attention-deficit\/hyperactivity disorder and cocaine dependence","volume":"25","author":"Notzon","year":"2016","journal-title":"Am J Addict"},{"issue":"5","key":"10.1016\/j.psc.2023.03.007_bib13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41593-020-0611-0","article-title":"Deconstructing the neurobiology of cannabis use disorder","volume":"23","author":"Ferland","year":"2020","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.psc.2023.03.007_bib14","article-title":"The impact of recreational cannabis legalization on youth: the Colorado experience","author":"Hinckley","year":"2022","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"5","key":"10.1016\/j.psc.2023.03.007_bib15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1176\/appi.ajp.2008.07091465","article-title":"Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood","volume":"165","author":"Mannuzza","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2023.03.007_bib16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/10826084.2013.841251","article-title":"Subtypes of attention deficit-hyperactivity disorder (ADHD) and cannabis use","volume":"49","author":"Loflin","year":"2014","journal-title":"Subst Use Misuse"},{"issue":"2","key":"10.1016\/j.psc.2023.03.007_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/jcpp.12899","article-title":"Practitioner Review: emotional dysregulation in attention-deficit\/hyperactivity disorder - implications for clinical recognition and intervention","volume":"60","author":"Faraone","year":"2019","journal-title":"J\u00a0Child Psychol Psychiatry"},{"issue":"7","key":"10.1016\/j.psc.2023.03.007_bib18","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.cpr.2008.05.004","article-title":"A\u00a0conceptual review of the comorbidity of attention-deficit\/hyperactivity disorder and anxiety: implications for future research and practice","volume":"28","author":"Jarrett","year":"2008","journal-title":"Clin Psychol Rev"},{"issue":"8","key":"10.1016\/j.psc.2023.03.007_bib19","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jaac.2013.06.001","article-title":"Assessment and management of sleep problems in youths with attention-deficit\/hyperactivity disorder","volume":"52","author":"Cortese","year":"2013","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"10.1016\/j.psc.2023.03.007_bib20","doi-asserted-by":"crossref","first-page":"e12936","DOI":"10.1111\/jsr.12936","article-title":"Evening circadian preference is associated with sleep problems and daytime sleepiness in adolescents with ADHD","volume":"29","author":"Becker","year":"2020","journal-title":"J\u00a0Sleep Res"},{"issue":"9","key":"10.1016\/j.psc.2023.03.007_bib21","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jaac.2020.12.035","article-title":"Review: identification and management of circadian rhythm sleep disorders as a transdiagnostic feature in child and adolescent psychiatry","volume":"60","author":"Arns","year":"2021","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"12","key":"10.1016\/j.psc.2023.03.007_bib22","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s00787-020-01659-5","article-title":"ADHD subtypes are associated differently with circadian rhythms of motor activity, sleep disturbances, and body mass index in children and adolescents: a case-control study","volume":"30","author":"Zeron-Rugerio","year":"2021","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2023.03.007_bib23","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1001\/jamapsychiatry.2018.4500","article-title":"Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: a systematic review and meta-analysis","volume":"76","author":"Gobbi","year":"2019","journal-title":"JAMA psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2023.03.007_bib24","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1037\/a0037504","article-title":"Evaluation of underlying mechanisms in the link between childhood ADHD symptoms and risk for early initiation of substance use","volume":"28","author":"Vitulano","year":"2014","journal-title":"Psychol Addict Behav"},{"issue":"3","key":"10.1016\/j.psc.2023.03.007_bib25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1037\/adb0000059","article-title":"Internalizing and externalizing psychopathology as predictors of cannabis use disorder onset during adolescence and early adulthood","volume":"29","author":"Farmer","year":"2015","journal-title":"Psychol Addict Behav"},{"key":"10.1016\/j.psc.2023.03.007_bib26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jad.2020.12.043","article-title":"Comorbid cannabis use disorder with major depression and generalized anxiety disorder: a systematic review with meta-analysis of Nationally Representative Epidemiological surveys","volume":"281","author":"Onaemo","year":"2021","journal-title":"J\u00a0Affect Disord"},{"issue":"2","key":"10.1016\/j.psc.2023.03.007_bib27","first-page":"169","article-title":"Cannabis addiction and the brain: a review","volume":"17","author":"Zehra","year":"2019","journal-title":"Focus (Am Psychiatr Publ)"},{"key":"10.1016\/j.psc.2023.03.007_bib28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1146\/annurev.clinpsy.4.022007.141157","article-title":"Behavioral disinhibition and the development of early-onset addiction: common and specific influences","volume":"4","author":"Iacono","year":"2008","journal-title":"Annu Rev Clin Psychol"},{"issue":"5","key":"10.1016\/j.psc.2023.03.007_bib29","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/add.12880","article-title":"Developmental progression to early adult binge drinking and marijuana use from worsening versus stable trajectories of adolescent attention deficit\/hyperactivity disorder and delinquency","volume":"110","author":"Howard","year":"2015","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.psc.2023.03.007_bib30","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1037\/a0036585","article-title":"The role of early childhood ADHD and subsequent CD in the initiation and escalation of adolescent cigarette, alcohol, and marijuana use","volume":"123","author":"Sibley","year":"2014","journal-title":"J\u00a0Abnorm Psychol"},{"issue":"12","key":"10.1016\/j.psc.2023.03.007_bib31","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s10802-019-00573-y","article-title":"Depression and ADHD-related risk for substance use in adolescence and early adulthood: Concurrent and prospective associations in the MTA","volume":"47","author":"Howard","year":"2019","journal-title":"J\u00a0Abnorm Child Psychol"},{"issue":"7","key":"10.1016\/j.psc.2023.03.007_bib32","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1176\/appi.ajp.2020.19101008","article-title":"Association between the use of cannabis and physical violence in youths: a meta-Analytical investigation","volume":"177","author":"Dellazizzo","year":"2020","journal-title":"Am J Psychiatry"},{"issue":"7","key":"10.1016\/j.psc.2023.03.007_bib33","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/mp.2012.87","article-title":"Childhood trajectories of inattention, hyperactivity and oppositional behaviors and prediction of substance abuse\/dependence: a 15-year longitudinal population-based study","volume":"18","author":"Pingault","year":"2013","journal-title":"Mol Psychiatry"},{"issue":"7","key":"10.1016\/j.psc.2023.03.007_bib34","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/chi.0b013e318054e724","article-title":"Practice parameter for the assessment and treatment of children and adolescents with attention-deficit\/hyperactivity disorder","volume":"46","author":"Pliszka","year":"2007","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"18","key":"10.1016\/j.psc.2023.03.007_bib35","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/jama.2016.5453","article-title":"Treatment of attention-deficit\/hyperactivity disorder in adolescents: a systematic review","volume":"315","author":"Chan","year":"2016","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.psc.2023.03.007_bib36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0040-1701658","article-title":"ADHD: current Concepts and treatments in children and adolescents","volume":"51","author":"Drechsler","year":"2020","journal-title":"Neuropediatrics"},{"issue":"9","key":"10.1016\/j.psc.2023.03.007_bib37","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1177\/1087054715569280","article-title":"Treatments for adolescents with comorbid ADHD and substance use disorder: a systematic review","volume":"24","author":"Zaso","year":"2020","journal-title":"J\u00a0Atten Disord"},{"issue":"2","key":"10.1016\/j.psc.2023.03.007_bib38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/2210676611666210616163340","article-title":"Marijuana legalization in Colorado: Increasing potency, changing risk perceptions, and emerging public health concerns for youth","volume":"11","author":"Hinckley","year":"2021","journal-title":"Adolescent Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2023.03.007_bib39","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1590\/S0100-879X2008005000011","article-title":"A\u00a0randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit\/hyperactivity disorder symptoms in adolescents with substance use disorder","volume":"41","author":"Szobot","year":"2008","journal-title":"Braz J Med Biol Res"},{"issue":"9","key":"10.1016\/j.psc.2023.03.007_bib40","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jaac.2011.06.010","article-title":"Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit\/hyperactivity disorder and substance use disorders","volume":"50","author":"Riggs","year":"2011","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"10.1016\/j.psc.2023.03.007_bib41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/cap.2011.0014","article-title":"Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit\/hyperactivity disorder","volume":"21","author":"Winhusen","year":"2011","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"11","key":"10.1016\/j.psc.2023.03.007_bib42","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.euroneuro.2017.08.435","article-title":"Methylphenidate doses in Attention Deficit\/Hyperactivity Disorder and comorbid substance use disorders","volume":"27","author":"Skoglund","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"issue":"8","key":"10.1016\/j.psc.2023.03.007_bib43","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.4088\/JCP.0807e20","article-title":"Impact of substance use disorder on ADHD and its treatment","volume":"68","author":"Wilens","year":"2007","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.psc.2023.03.007_bib44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/1087054712468051","article-title":"Do stimulants reduce the risk for alcohol and substance use in youth with ADHD? A secondary analysis of a prospective, 24-month open-Label study of osmotic-release methylphenidate","volume":"21","author":"Hammerness","year":"2017","journal-title":"J\u00a0Atten Disord"},{"issue":"17","key":"10.1016\/j.psc.2023.03.007_bib45","article-title":"Treatment of adolescents with Concurrent substance use disorder and attention-deficit\/hyperactivity disorder: a systematic review","volume":"10","author":"Ozgen","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"Suppl 1","key":"10.1016\/j.psc.2023.03.007_bib46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/10550490601082783","article-title":"Treatment strategies for co-occurring ADHD and substance use disorders","volume":"16","author":"Mariani","year":"2007","journal-title":"Am J Addict"},{"issue":"6","key":"10.1016\/j.psc.2023.03.007_bib47","first-page":"573","article-title":"Randomized, controlled trial of atomoxetine for attention-deficit\/hyperactivity disorder in adolescents with substance use disorder","volume":"49","author":"Thurstone","year":"2010","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"12","key":"10.1016\/j.psc.2023.03.007_bib48","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/00004583-199812000-00010","article-title":"An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder","volume":"37","author":"Riggs","year":"1998","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"10.1016\/j.psc.2023.03.007_bib49","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1089\/cap.2005.15.777","article-title":"Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit\/hyperactivity disorder and mood disorders","volume":"15","author":"Solhkhah","year":"2005","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"1","key":"10.1016\/j.psc.2023.03.007_bib50","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1176\/appi.neuropsych.16120328","article-title":"Guanfacine Attenuates adverse effects of Dronabinol (THC) on working memory in adolescent-onset heavy cannabis users: a pilot study","volume":"30","author":"Mathai","year":"2018","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"10.1016\/j.psc.2023.03.007_bib51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11920-017-0755-0","article-title":"Treating mental health and substance use disorders in adolescents: what is on the Menu?","volume":"19","author":"Brewer","year":"2017","journal-title":"Curr Psychiatry Rep"},{"issue":"4","key":"10.1016\/j.psc.2023.03.007_bib52","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/08897077.2014.936993","article-title":"The Adolescent Community Reinforcement Approach (A-CRA) as a model paradigm for the management of adolescents with substance use disorders and co-occurring psychiatric disorders","volume":"35","author":"Godley","year":"2014","journal-title":"Subst Abus"}],"container-title":["Psychiatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X23000321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X23000321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T01:42:37Z","timestamp":1759282957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0193953X23000321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0193953X23000321"],"URL":"https:\/\/doi.org\/10.1016\/j.psc.2023.03.007","relation":{},"ISSN":["0193-953X"],"issn-type":[{"type":"print","value":"0193-953X"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adolescent Cannabis Use, Comorbid Attention-Deficit\/Hyperactivity Disorder, and Other Internalizing and Externalizing Disorders","name":"articletitle","label":"Article Title"},{"value":"Psychiatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psc.2023.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}